MedTrace Logo

CoolSculpting the Upper Arm Study

NCT02669329 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-11-04

Study results available
· View outcomes & findings →

Summary

Evaluate the safety and efficacy of the ZELTIQ CoolSculpting System using a specialized surface applicator for non-invasive subcutaneous fat reduction in the upper arm.

Conditions

  • Body Fat Disorder

Interventions

DEVICE

CoolSculpting device with vacuum applicator.

The CoolSculpting device with a vacuum applicator will be used to perform the treatments.

Sponsors & Collaborators

  • Zeltiq Aesthetics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-05
Primary Completion
2016-06-07
Completion
2016-06-07
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02669329 on ClinicalTrials.gov